Bioactivity and safety of B7‐H3‐targeted chimeric antigen receptor T cells against anaplastic meningioma

OBJECTIVE: We conducted a first‐in‐human study to evaluate the bioactivity and safety of B7‐H3‐targeted chimeric antigen receptor (CAR) autologous T cells for treating recurrent anaplastic meningioma. METHODS: Tumor tissues from a patient with recurrent anaplastic meningioma were evaluated for B7‐H3...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Xin, Liu, Fujun, Liu, Zhiyong, Cao, Yi, Zhang, Zongliang, Wang, Yuelong, Huang, Jianhan, Fan, Shuangming, Zhao, Shasha, Chen, Yaxin, Li, Gaowei, Wang, Shan, Zheng, Meijun, Hu, Yating, Li, Hongjian, Jiang, Caiying, Yang, Meijia, Yang, Hui, Xu, JianGuo, Guo, Gang, Tong, Aiping, Zhou, Liangxue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292833/
https://www.ncbi.nlm.nih.gov/pubmed/32547742
http://dx.doi.org/10.1002/cti2.1137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292833/
https://www.ncbi.nlm.nih.gov/pubmed/32547742
http://dx.doi.org/10.1002/cti2.1137

Ejemplares similares